Exagen adopts amended executive severance plan with enhanced CIC and non-CIC benefits

EXAGEN INC.

Plan covers CEO Rocca, CFO Adawi, COO Hazeltine, and CMO Debra Zack.
Non-CIC termination: cash severance of 50% (75% for CEO) of base salary plus COBRA for 6 (9 for CEO) months.
CIC termination: cash severance of 100% (125% for CEO) of base salary, COBRA for 12 (15 for CEO) months, and full equity vesting.
Payments require execution of a general release of claims.
Plan effective April 25, 2022; supersedes prior severance arrangements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.